Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.31 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.31 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.31 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4079098 | 0.87 | — | — | |
| SCHEMBL703595 | 0.87 | ADRB2 (0.36) | DNM1ADRB2ADRB1ADRB3 | |
| SCHEMBL706696 | 0.85 | ADRB2 (0.35) | DNM1ADRB2ADRB1ADRB3 | |
| SCHEMBL705365 | 0.85 | ADRB2 (0.35) | DNM1ADRB2ADRB1ADRB3 | |
| SCHEMBL4090919 | 0.83 | DNM1 (0.33) | DNM1ADRB2ADRB1ADRB3 | |
| SCHEMBL2552187 | 0.79 | DNM1 (0.39) | DNM1ADRB2ADRB1ADRB3 | |
| SCHEMBL703587 | 0.78 | ADRB2 (0.36) | DNM1ADRB2ADRB1ADRB3 | |
| SCHEMBL1066786 | 0.78 | THRB (0.35) | — | |
| SCHEMBL375870 | 0.78 | DNM1 (0.31) | DNM1ADRB2ADRB1ADRB3 | |
| SCHEMBL7760600 | 0.78 | TSHR (0.39) | DNM1ADRB2ADRB1ADRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1915399-B1 | RECOVERABLE POLYMER-BOUND HOMOGENEOUS CATALYSTS FOR CATALYTIC CHAIN TRANSFER PROCESSES | COATINGS FOREIGN IP CO LLC (US) | 2013-11-20 | — | — | EP | claimed |
| US-8030422-B2 | Recoverable polymer-bound homogeneous catalysts for catalytic chain transfer process | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-10-04 | — | — | US | claimed |
| EP-1915399-A1 | RECOVERABLE POLYMER-BOUND HOMOGENEOUS CATALYSTS FOR CATALYTIC CHAIN TRANSFER PROCESSES | E.I.Du pont de nemours and company (US) | 2008-04-30 | — | — | EP | claimed |
| WO-2007024634-A1 | RECOVERABLE POLYMER-BOUND HOMOGENEOUS CATALYSTS FOR CATALYTIC CHAIN TRANSFER PROCESSES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-03-01 | — | — | WO | claimed |
| EP-0791016-A1 | POLYMER SYNTHESIS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-08-27 | — | — | EP | claimed |
| WO-1996015157-A1 | POLYMER SYNTHESIS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-05-23 | — | — | WO | claimed |
| EP-2970538-B1 | POLYMERIZATION PROCESS PROTECTION MEANS | DUPONT ELECTRONICS INC (US) | 2021-10-20 | — | — | EP | disclosed |
| CN-107428955-B | Proton binding polymers for oral administration | 特里赛达公司 | 2021-09-21 | — | — | CN | disclosed |
| US-9925214-B2 | Proton-binding polymers for oral administration | TRICIDA, INC. (US) | 2018-03-27 | — | — | US | disclosed |
| WO-2016123675-A1 | TARGETING CONSTRUCTS FOR DELIVERY OF PAYLOADS | THE UNIVERSITY OF QUEENSLAND (AU) | 2016-08-11 | — | — | WO | disclosed |
| US-20160074430-A1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | RENIBUS THERAPEUTICS, INC. | 2016-03-17 | — | — | US | disclosed |
| EP-2970538-A1 | POLYMERIZATION PROCESS PROTECTION MEANS | E. I. du Pont de Nemours and Company (US) | 2016-01-20 | — | — | EP | disclosed |
| WO-2014150700-A1 | POLYMERIZATION PROCESS PROTECTION MEANS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2014-09-25 | — | — | WO | disclosed |
| WO-2007070724-A2 | PIGMENT DISPERSIONS CONTAINING AMINATED ACRYLIC MACROMONOMER DISPERSANT | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-06-21 | — | — | WO | disclosed |
| EP-1786552-A1 | METHOD OF MAKING POLYMER MONOLITH COMPOSITE SUBSTRATE AND RESULTING SUBSTRATE AS WELL AS BEADS AND BEAD ARRAY | Applera Corporation (US) | 2007-05-23 | — | — | EP | disclosed |
| WO-2007024634-A1 | RECOVERABLE POLYMER-BOUND HOMOGENEOUS CATALYSTS FOR CATALYTIC CHAIN TRANSFER PROCESSES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-03-01 | — | — | WO | disclosed |
| US-20060078983-A1 | Polymer monolith substrate | APPLERA CORPORATION (US) | 2006-04-13 | — | — | US | disclosed |
| EP-1639019-A1 | PRESSURIZED HIGH TEMPERATURE POLYMERIZATION PROCESS | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2006-03-29 | — | — | EP | disclosed |
| WO-2006026378-A1 | METHOD OF MAKING POLYMER MONOLITH COMPOSITE SUBSTRATE AND RESULTING SUBSTRATE AS WELL AS BEADS AND BEAD ARRAY | APPLERA CORPORATION (US) | 2006-03-09 | — | — | WO | disclosed |
| WO-2005003185-A1 | PRESSURIZED HIGH TEMPERATURE POLYMERIZATION PROCESS | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2005-01-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160074430-A1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | SLC9A1, HRH2, SLC9A2 | DNM1 650/4885ADRB2 4338/4885ADRB1 4371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.